PREVIOUS ISSUE NEXT ISSUE
April 2016 MHE0416_CV1.jpg
Five reasons diabetic patients don’t adhere… and solutions from experts
Do prescription drug monitoring programs work?An in-depth look at the effects of PDMPs, which are electronic databases used to track the prescribing and dispensing of controlled prescription drugs to patients.
Are EHRs delivering on expectations?Concerns among stakeholders may call for EHR system revamping
Successful payer-provider collaborations: 4 characteristicsWhile value-based reimbursement presents opportunities for payers and providers, succeeding in such a reimbursement model can be challenging. Here are four things to strive for that could increase the likelihood of success in a value-based reimbursement model.
Innovative diabetes cost-reduction strategiesHere are some of the innovative approaches payers and providers are taking to quell the diabetes epidemic, and curb the costs associated with it.
Undiagnosed diabetes: A high cost for the health systemConsequences range from cardiovascular disease to renal disease
Diabetes drug spending on the riseThe sheer volume of diabetes patients has made it a big driver of medication spending. Here are some important formulary considerations.
Analytics puts power in the hands of patients, payers, physiciansThere is so much data available at all levels of healthcare, and technology and public support is on the cusp of a breakthrough in using this information for widespread improvements.
Top ways to manage cost of infusible specialty therapiesWhile the high cost of specialty pharmacy is no surprise in the healthcare industry, infusibles have additional challenges. Here are the challenges that top the list, and what to do about them.
Legal considerations surrounding ‘big data’State and federal regulations, health information breaches, create a minefield of issues
PREVIOUS ISSUE NEXT ISSUE